Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 2H2S9 | — |
Expired dose given; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 1-year-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (batch number 2H2S9, expiry date 11-JUN-2025) for prophylaxis. On 29-OCT-2025, the patient received the 1st dose of FluLaval 2024-2025 season. On an unknown date, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 04-SEP-2025 MD called to inform about an expired vaccine that was given to a child, it was FluLaval.. Also, reporter mentioned that it was the 1st dose of the patient.